Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer
Clinical trial NCT03430466 · TERMINATED
Trial details
- NCT number
- NCT03430466
- Sponsor
- Kyoto Breast Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2018-01-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.